RxNorm Semantic Concepts Index - 556
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "556".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 55627 | Rhizopus aspartic proteinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 55627 | Rhizopus aspartic proteinase | Designated preferred name (PT) | NO | |
| RxCUI: 55627 | Rhizopus aspartic proteinase | Full form of descriptor (FN) | NO | |
| RxCUI: 55629 | Anti D | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 55629 | Anti D | Designated preferred name (PT) | NO | |
| RxCUI: 55629 | Anti D | Full form of descriptor (FN) | NO | |
| RxCUI: 55629 | Anti D | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 55629 | Anti D | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 55629 | Anti D | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 55672 | Rifabutin | Full form of descriptor (FN) | YES | |
| RxCUI: 55672 | Rifabutin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 55672 | Rifabutin | Designated preferred name (PT) | YES | |
| RxCUI: 55672 | Rifabutin | Full form of descriptor (FN) | YES | |
| RxCUI: 55672 | Rifabutin | Designated preferred name (PT) | YES | |
| RxCUI: 55679 | rilmenidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 55679 | rilmenidine | Designated preferred name (PT) | NO | |
| RxCUI: 55679 | rilmenidine | Full form of descriptor (FN) | NO | |
| RxCUI: 55681 | rimexolone | Full form of descriptor (FN) | NO | |
| RxCUI: 55681 | rimexolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 55681 | rimexolone | Designated preferred name (PT) | NO | |
| RxCUI: 55681 | rimexolone | Full form of descriptor (FN) | NO | |
| RxCUI: 55681 | rimexolone | Designated preferred name (PT) | NO | |
| RxCUI: 55685 | risedronic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 55685 | risedronic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 55685 | risedronic acid | Designated preferred name (PT) | YES | |
| RxCUI: 55685 | risedronic acid | Full form of descriptor (FN) | YES | |
| RxCUI: 55685 | risedronic acid | Designated preferred name (PT) | YES |